Sponsored by Open Therapeutics. Matching funds are being sought. Details coming soon...
New development of oHSV-Gluc biotechnology
Sponsored by: Open Therapeutics™
This grant will award up to $2,000.00 towards the winning proposal(s).
Proposals that utilize the following Technologies will be considered: oncolytic herpes simplex virus (oHSV)-Gluc for cancer screening
From 2018-09-01 22:00 UTC to 2018-10-01 22:00 UTC